BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $85,000 | -22.7% | 2,828 | +11.4% | 0.00% | -33.3% |
| Q4 2020 | $110,000 | +5400.0% | 2,538 | +6578.9% | 0.01% | – |
| Q3 2020 | $2,000 | 0.0% | 38 | -5.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 40 | +5.3% | 0.00% | – |
| Q1 2020 | $2,000 | -77.8% | 38 | -62.0% | 0.00% | -100.0% |
| Q4 2019 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | -30.8% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | -18.8% | 100 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $16,000 | +60.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $11,000 | -31.2% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $16,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |